Cargando…
Corrigendum to ‘Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma’ [Am. J. Ophthalmol. Case Reports (4) (2016) 7–10]
Autores principales: | Zafar, Sidra, Burq, M.A., Iftikhar, Mustafa, Ali, Azam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5758034/ https://www.ncbi.nlm.nih.gov/pubmed/29505037 http://dx.doi.org/10.1016/j.ajoc.2017.02.004 |
Ejemplares similares
-
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
por: Zafar, Sidra, et al.
Publicado: (2016) -
Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
por: Sarıgül Sezenöz, Almila, et al.
Publicado: (2017) -
Long-Term Follow-Up of Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization due to Choroidal Osteoma
por: H.Y. Wu, Zenith, et al.
Publicado: (2012) -
Combination therapy of low-fluence photodynamic therapy and intravitreal ranibizumab for choroidal neovascular membrane in choroidal osteoma
por: Morris, Rodney J, et al.
Publicado: (2011) -
Intravitreal Bevacizumab for Management of Choroidal Osteoma without Choroidal Neovascularization
por: Najafabadi, Farhad Fazel, et al.
Publicado: (2015)